The phenomenon of non-adherence to statin therapy is well known. Reasons for discontinuation include elevated hepatic or muscular enzymes, neurological symptoms, and muscular symptoms collectively referred to as statin-associated muscle symptoms (SAMS).1 SAMS seems to occur less frequently in randomized control trials than in observational studies. These results suggest that … [Read more...] about SAMSON Trial: Role of nocebo effect in statin-associated muscle symptoms
Cardiology research news
Top 10 Highlights of AHA 2020 Congress
The American Heart Association (AHA) 2020 congress took place virtually this year, from November 13 to 17, 2020. Here is our curated list of the top scientific sessions from AHA 2020. SOLOIST-WHF trial1: Sotagliflozin superior to placebo in preventing deaths and hospitalizations in patients with type 2 diabetes and worsening heart failure. This multicenter, double-blind … [Read more...] about Top 10 Highlights of AHA 2020 Congress
Thromboembolism in COVID-19 patients despite thromboprophylaxis
Cardiovascular events are frequently seen in association with coronavirus disease-2019 (COVID-19), particularly thromboembolisms. Researchers from Brigham and Women’s Hospital in Massachusetts just published results from their multicentre, observational cohort study investigating thromboembolism in patients with COVID-19 (COVID-19 Registry to Assess Frequency, Risk Factors, … [Read more...] about Thromboembolism in COVID-19 patients despite thromboprophylaxis
Top 10 highlights of TCT 2020 Congress
This year the Transcatheter Cardiovascular Therapeutics (TCT, TCT Connect 2020) congress was held as a virtual event October14 - 18, 2020, broadcasting live case-based transmissions from around the world, late-breaking clinical trials and virtual training in interventional cardiovascular medicine. Here is our curated list of the top 10 highlights of the symposium (TCT … [Read more...] about Top 10 highlights of TCT 2020 Congress
Very late stent-related events may occur in 50% of patients
Most literature describing stent-related major adverse cardiovascular events (MACE) following percutaneous coronary intervention (PCI) consider only the first year post-intervention. Very little is known about the frequency and predictors of very-late stent-related events (>1 year and ≤5 years post-intervention), or MACE by stent type. This large-scale, individual patient data … [Read more...] about Very late stent-related events may occur in 50% of patients